<html>
<head>
  <title>SARS-CoV-2 Spike protein (S) gene E484D literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="S.html">Spike protein (S)</a> gene <span class="constellation">S:p.E484D</span> literature reference collection</h1>
<div class="effect_section"><h2 id="ACE2_receptor_binding_affinity">ACE2 receptor binding affinity</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> In a soluble human ACE2-Fc receptor decoy inhibition experiment, this mutation showed a 4.6x drop in sensitivity. <br/> (<a href="https://doi.org/10.1016/j.chom.2021.01.014" class="lit_link">Liu et al. (2020)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> In a soluble human ACE2-Fc receptor decoy inhibition experiment, this mutation showed a ~4x drop in sensitivity. <br/> (<a href="https://doi.org/10.1016/j.chom.2021.01.014" class="lit_link">Liu et al. (2020)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="antibody_epitope_effects">Antibody epitope effects</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Highly resistant to mAb 1B07 of 10 antibodies tested, and moderately high resistance to the remaining.<br/> (<a href="https://doi.org/10.1016/j.chom.2021.01.014" class="lit_link">Liu et al. (2020)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> For highly potent RBD-binding neutralizing antibody ADI-56443 this mutation causes ablation of neutralization efficiency.<br/> (<a href="https://doi.org/10.1101/2021.06.10.447999" class="lit_link">Haslwanter et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Nearly complete loss of binding in ELISA by the variant against monoclonal antibody VH-Fc ab8.<br/> >20% (ELISA significance threshold) drop in antibody binding by this variant against IgG1 monoclonal antibody ab1.<br/> (<a href="https://doi.org/10.1101/2021.03.22.436481" class="lit_link">Sun et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Mutant screen in neutralization assay with a broad range of monoclonal antibodies shows resistence to mAb 1B07.<br/> (<a href="https://doi.org/10.1101/2020.11.06.372037" class="lit_link">Liu et al. (2020)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Massive reduction in binding efficiency vs wild type for mAb LY-CoV555.<br/> (<a href="https://doi.org/10.1126/science.abf4830" class="lit_link">Rappazzo et al. (2021)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="convalescent_plasma_escape">Convalescent plasma escape</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Significant decrease in neutralization across 15 of 16 sera tested 7-17 days post symptoms onset.<br/> (<a href="https://doi.org/10.1016/j.chom.2021.01.014" class="lit_link">Liu et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> No effective neutralization in all 4 out of the 4 sera tested.<br/> (<a href="https://doi.org/10.1016/j.chom.2021.01.014" class="lit_link">Liu et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Remarkably, several of the E484 escape mutants were resistant to neutralization at the highest concentration (1:80 initial dilution) of all 4 convalescent sera tested.<br/>Against a wider panel of 16 convalescent plasma (no replicates), all but one show major resistance. (<a href="https://doi.org/10.1101/2020.11.06.372037" class="lit_link">Liu et al. (2021)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="monoclonal_antibody_serial_passage_escape">Monoclonal antibody serial passage escape</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Escape mutation against monoclonal antibody LY-CoV555 (antibody that forms the basis for Eli Lilly's bamlanivimab) (<a href="https://doi.org/10.1101/2021.02.17.431683" class="lit_link">Starr et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Class 2 mAb C602 mildly selected for the emergence of this mutation in vitro.<br/> (<a href="https://doi.org/10.1101/2021.01.15.426911" class="lit_link">Wang et al. (2021)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
